Injectable Hydrogel Electrodes Open Door to a Novel Painless Treatment Regimen for Arrhythmia (IMAGE)

Texas Heart Institute

Injectable Hydrogel Electrodes Open Door to a Novel Painless Treatment Regimen for Arrhythmia

Caption

A breakthrough study led by Dr. Mehdi Razavi at The Texas Heart Institute (THI), in collaboration with a chemical and biomedical engineering team of The University of Texas at Austin (UT Austin) Cockrell School of Engineering led by Dr. Elizabeth Cosgriff-Hernandez, sets the foundation of a ground-breaking treatment regimen for treating ventricular arrhythmia.  Their study published in Nature Communications demonstrates the design and feasibility of a new hydrogel-based pacing modality. The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management. Pictured Allison Post, PhD and Mehdi Razavi, MD (The Texas Heart Institue).

Credit

© The Texas Heart Institute 2024

Usage Restrictions

Credit Source

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.